Home Tags Tumor microenvironment

Tag: Tumor microenvironment

CytomX Therapeutics Acquires Technologies Developed by Agensys

Peter Hofland
Clinical-stage and oncology-focused biopharmaceutical company CytomX Therapeutics, pioneering a novel class of investigational antibody therapeutics based on its Probody™ therapeutic technology platform, has acquired...

Cutting-Edge Science: Personalized Drug Screening for Multiple Myeloma

ADC Review | Editorial Team
In the decades old "war" against cancer, scientist are increasingly developing ore and better ways to help doctors address the unmet medical needs of...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X